APA (7th ed.) Citation

M, S., Y, A., CL, A., MC, B., V, S., E, E., . . . CO, H. (2025). Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas. EBioMedicine, 117, 105814. https://doi.org/10.1016/j.ebiom.2025.105814

Chicago Style (17th ed.) Citation

M, Shah, et al. "Integrated Proteomic and Targeted Next Generation Sequencing Reveal Relevant Heterogeneity in Lower-grade Meningioma and ANXA3 as a New Target in NF2 Mutated Meningiomas." EBioMedicine 117 (2025): 105814. https://doi.org/10.1016/j.ebiom.2025.105814.

MLA (9th ed.) Citation

M, Shah, et al. "Integrated Proteomic and Targeted Next Generation Sequencing Reveal Relevant Heterogeneity in Lower-grade Meningioma and ANXA3 as a New Target in NF2 Mutated Meningiomas." EBioMedicine, vol. 117, 2025, p. 105814, https://doi.org/10.1016/j.ebiom.2025.105814.